Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1) (Q83451435)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

retinal vein occlusion

1 reference

1 reference

Siamak Moradian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Hooshang Faghihi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Babak Sadeghi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Niloofar Piri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Hamid Ahmadieh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Masoud Soheilian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Mohammad Hossein Dehghan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Mohsen Azarmina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Mohammad Riazi Esfahani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

18 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

Graefe's Archive for Clinical and Experimental Ophthalmology

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

193-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337043%20AND%20SRC:MED&resulttype=core&format=json

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

23 January 2020

cites work

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

1 reference

12 December 2020

Morphology of early retinal lesions after experimental venous occlusion

1 reference

12 December 2020

Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion

1 reference

12 December 2020

Multiple laser treatments for macular edema attributable to branch retinal vein occlusion

1 reference

12 December 2020

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

1 reference

12 December 2020

Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.

1 reference

12 December 2020

Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study

1 reference

12 December 2020

Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab

1 reference

12 December 2020

Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion

1 reference

12 December 2020

Macular oedema and retinal branch vein occlusion

1 reference

12 December 2020

SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion

1 reference

12 December 2020

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]

1 reference

12 December 2020

Cataract formation and other complications of intravitreal triamcinolone for macular edema

1 reference

12 December 2020

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

1 reference

12 December 2020

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

1 reference

12 December 2020

Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.

1 reference

12 December 2020

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

1 reference

12 December 2020

Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion

1 reference

12 December 2020

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

12 December 2020

Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease

1 reference

12 December 2020

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group

1 reference

12 December 2020

Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts

1 reference

12 December 2020

Vascular endothelial growth factor upregulation in human central retinal vein occlusion

1 reference

12 December 2020

Results of laser coagulation of retinal branch vein occlusions

1 reference

12 December 2020

Ocular side effects and complications of intravitreal triamcinolone acetonide injection

1 reference

12 December 2020

The 30-Hz flicker cone ERG for monitoring the early course of central retinal vein occlusion

1 reference

12 December 2020

Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial

1 reference

12 December 2020

One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion

1 reference

12 December 2020

Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study

1 reference

12 December 2020

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal [...]

1 reference

12 December 2020